SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015962
Filing Date
2021-11-15
Accepted
2021-11-15 16:03:37
Documents
82
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrxp-20210930x10q.htm   iXBRL 10-Q 1977084
2 EX-10.1 nrxp-20210930xex10d1.htm EX-10.1 327346
3 EX-31.1 nrxp-20210930xex31d1.htm EX-31.1 15359
4 EX-31.2 nrxp-20210930xex31d2.htm EX-31.2 15432
5 EX-32.1 nrxp-20210930xex32d1.htm EX-32.1 7087
6 EX-32.2 nrxp-20210930xex32d2.htm EX-32.2 6424
7 GRAPHIC nrxp-20210930xex10d1001.jpg GRAPHIC 6951
  Complete submission text file 0001558370-21-015962.txt   9053553

Data Files

Seq Description Document Type Size
8 EX-101.SCH nrxp-20210930.xsd EX-101.SCH 85815
9 EX-101.CAL nrxp-20210930_cal.xml EX-101.CAL 42433
10 EX-101.DEF nrxp-20210930_def.xml EX-101.DEF 331463
11 EX-101.LAB nrxp-20210930_lab.xml EX-101.LAB 547256
12 EX-101.PRE nrxp-20210930_pre.xml EX-101.PRE 520462
13 EXTRACTED XBRL INSTANCE DOCUMENT nrxp-20210930x10q_htm.xml XML 1390144
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38302 | Film No.: 211410219
SIC: 2834 Pharmaceutical Preparations